City Therapeutics
PrivateLast Round
Series B
Jun 8, 2026
Total Funding Raised
$264.5M
Momentum Score
25 /100
Company Overview
City Therapeutics is a biotechnology company dedicated to developing innovative RNAi-based treatments that target and degrade harmful gene expression, providing healthcare professionals with more effective options for diseases with limited therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
City Therapeutics Comps
Public and private peers based on sector, stage, and business model.
City Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2026 | ||||
| Convertible Debt | May 27, 2025 | ||||
| Series A | Oct 8, 2024 |
City Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series B |
| Fidelity Management & Research Company | Series B, Series A |
| ARCH Venture Partners | Series A |
| Viking Global Investors | Series B |
| AN Venture Partners | Series B |
| Casdin Capital | Series B |
| Rock Springs Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2026
$100M round led by Viking Global Investors and Sofinnova Investments.
City Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about City Therapeutics's valuation, stock price, and market status.
